Craniosynostosis-fibular aplasia syndrome
Craniosynostosis-fibular aplasia syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis) and the absence or underdevelopment of the fibula (fibular aplasia). This syndrome is also associated with a range of other physical abnormalities.
Symptoms and Signs[edit | edit source]
The primary symptoms of Craniosynostosis-fibular aplasia syndrome include craniosynostosis, which is the premature fusion of the skull bones, and fibular aplasia, which is the absence or underdevelopment of the fibula. Other symptoms may include facial asymmetry, micrognathia (small lower jaw), microcephaly (small head size), and brachydactyly (short fingers and toes). Some individuals may also have intellectual disability and growth retardation.
Causes[edit | edit source]
The exact cause of Craniosynostosis-fibular aplasia syndrome is currently unknown. However, it is believed to be a genetic disorder, possibly inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the defective gene, one from each parent, in order to develop the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Craniosynostosis-fibular aplasia syndrome is typically based on the presence of characteristic physical abnormalities. Genetic testing may also be used to confirm the diagnosis and identify the specific gene mutation.
Treatment[edit | edit source]
Treatment for Craniosynostosis-fibular aplasia syndrome is typically focused on managing the individual symptoms. This may include surgery to correct craniosynostosis, physical therapy to improve mobility, and special education services for those with intellectual disability.
Prognosis[edit | edit source]
The prognosis for individuals with Craniosynostosis-fibular aplasia syndrome varies depending on the severity of the symptoms. With appropriate treatment and support, many individuals can lead fulfilling lives.
See Also[edit | edit source]
Craniosynostosis-fibular aplasia syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD